Clarke, K <br/><br/>
Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jun 1998 
 - 2181-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1998.16.6.2181  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibiotics, Antineoplastic--pharmacokinetics<br/>Carubicin--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Filgrastim<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Neutropenia--chemically induced<br/>Recombinant Proteins<br/>Treatment Outcome